IRVINE, Calif., April 25, 2018 -- Sabra Health Care REIT, Inc. (NASDAQ:SBRA) (NASDAQ:SBRAP) announced today that it will issue its 2018 first quarter earnings release on May 9, 2018.
A conference call with a simultaneous webcast to discuss the 2018 first quarter earnings will be held on Thursday, May 10 at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 844-862-3710. For participants outside the U.S., the dial-in number is 612-979-9902. The conference ID number is 6176379.
The webcast URL is https://edge.media-server.com/m6/p/on7ijarn
A digital replay of the call will be available on our website at www.sabrahealth.com.
ABOUT SABRA
Sabra Health Care REIT, Inc. (Nasdaq:SBRA) (Nasdaq:SBRAP), a Maryland corporation, operates as a self-administered, self-managed real estate investment trust (a "REIT") that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada.
CONTACT
Investor & Media Inquiries: 1-888-393-8248 or [email protected]


OpenAI GPT-5.6 Set for Wider Release After U.S. Commerce Approval, Report Says
Japan Regional Bank Stocks Drop After Zentoshin Bankruptcy Sparks Credit Risk Concerns
Nvidia Invests $500M in Firmus Technologies Ahead of Planned ASX IPO
Oil and LNG Tankers Turn Back as Strait of Hormuz Security Risks Escalate
Bernstein Names IAG, Ryanair as Top European Airline Stocks Ahead of Earnings
BHP Faces Port Hedland Strike Threat as Iron Ore Export Risks Grow
OpenAI Executive Fidji Simo to Step Down Amid Health Challenges Ahead of IPO
Zhipu AI Raises HK$31.37 Billion in Discounted Share Sale to Accelerate AI Growth
Apple Sues OpenAI, Former Employees Over Alleged Trade Secret Theft
Oppenheimer Sees CNH Industrial as Top 2026 Agriculture Stock Pick on Dealer Consolidation Strategy
Morgan Stanley Names Marks & Spencer Top European Retail Pick, Sees Strong Upside
Elon Musk Says Anthropic Leads AI Race as Claude Models Challenge OpenAI
SK Hynix Soars 13% in Nasdaq Debut After Record $26.5 Billion IPO
Levi Strauss Raises 2026 Outlook After Q2 Earnings Beat, Shares Drop Despite Strong Results
Bain Capital Exits Kioxia After AI-Fueled Valuation Surge
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
SK Hynix Prices Record U.S. ADR Offering at $149 After $200 Billion Investor Demand 



